DIAGNOSIS TECHNOLOGY

Robots are making advances in many areas of healthcare and medicine, and the most popular vision is that of surgical robots. However, AURA is focused in diagnostic tools.

DISEASE AND DISORDER DIAGNOSIS

AURA’s OSCANN is a diagnosis platform for neurological disorders based on the analysis of eye movements, which are a complex output of the Nervous System (NS). Data acquired through instrumental eye movement examination and other clinical data can be analysed by new data mining and artificial intelligence techniques to increase our ability to discriminate precisely between different neurological diseases.

DIAGNOSIS OF ALZHEIMER DISEASE

Alzheimer disease is featured by recent memory impairment (initially mere details of daily life), disorientation, inability to recognize familiar people, decreased intellectual performance and language issues that lead to the loss of language ability. Motor skills are also impaired, including eye movement.
Until now, there is no evidence of a definitive diagnosis technique, and certainty can only be achieved late, by means of pathologic studies in the autopsy. However, growing evidence supports surrogate techniques of diagnosis. Eye movement analysis combined with other clinical data could improve the reliability of the diagnosis process.

DIAGNOSIS OF PARKINSON

Parkinson’s disease is caused by a loss of nerve cells in the substantia nigra. Nerve cells in this part of the brain are responsible for producing a chemical called dopamine. Dopamine acts as a messenger between the parts of the brain and nervous system that help control and co-ordinate body movements. If these nerve cells die or become damaged, the amount of dopamine in the brain is reduced. This means the part of the brain controlling movement can’t work as well as normal, causing movements to become slow and abnormal. The loss of nerve cells is a slow process. The symptoms of Parkinson’s disease usually only start to develop when around 80% of the nerve cells in the substantia nigra have been lost. Source: nhsinform.scot

DIAGNOSIS OF MINIMAL HEPATIC ENCEPHALOPATHY

Hepatic Encephalopathy (HE) is a deterioration in brain function observed in people with acute liver failure of chronic liver disease. The brain is a very sensitive organ and relies on a healthy liver in order to properly function. Symptoms and signs of HE vary from mild to severe. In the mild stage of HE, called minimal HE (MHE) or covert HE (CHE), a person’s ability to carry out daily tasks (working, driving, sleeping) is affected and as a result, leads to poor quality of life. A person suffering from MHE may experience anxiety, problems concentrating, poor memory or are unable to think clearly. Source: liver.ca

DIAGNOSIS OF PARKINSONISMS

Parkinsonism is a general term that refers to a group of neurological disorders that cause movement problems similar to those seen in Parkinson’s disease such as tremors, slow movement and stiffness. Under the category of parkinsonism there are a number of disorders, some of which have yet to be clearly defined or named. Early in the disease process, it is often hard to know whether a person has idiopathic (meaning “of unknown origins”) Parkinson’s disease or a syndrome that mimics it. Parkinsonisms, also known as atypical Parkinson’s disease or Parkinson’s plus, represent about 10-15% of all diagnosed cases of parkinsonism.

DIAGNOSIS OF FRONTOTEMPORAL DEMENTIA

Mild cognitive impairment (MCI) is a condition in which someone has minor problems with cognition – their mental abilities such as memory or thinking. In MCI these difficulties are worse than would normally be expected for a healthy person of their age. However, the symptoms are not severe enough to interfere significantly with daily life, and so are not defined as dementia. It is estimated that between 5 and 20% of people aged over 65 have MCI. It is not a type of dementia, but a person with MCI is more likely to go on to develop dementia. Source: alzheimers.org.uk

KEY FACTS

SCOPE

1 BILLION

People worldwide suffer from some kind of neurological disorder

DEMENTIA

80 MILLION

People Worldwide

ALZHEIMER

UP TO 80%

Of dementia cases are accounted as Alzheimer's

PARKINSON

9 MILLION

People Worldwide

Contact us

Please fill in the form and we will get in touch as soon as possible